Schmidt D - Search Results

1

Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.

Albers P, Ko Y, Wardelmann E, Schmidt D, Adam M, Vetter H, Müller SC. Albers P, et al. Among authors: schmidt d. Anticancer Res. 2000 May-Jun;20(3B):2107-11. Anticancer Res. 2000. PMID: 10928161

2

p53 immunoreactivity in biopsy specimens of T1G3 transitional cell carcinoma of the bladder--a helpful parameter in guiding the decision for or against cystectomy?

Steiner G, Bierhoff E, Schmidt D, Leissner J, Wolf HK, Albers P. Steiner G, et al. Among authors: schmidt d. Eur J Cancer. 2000 Mar;36(5):610-4. doi: 10.1016/s0959-8049(99)00325-1. Eur J Cancer. 2000. PMID: 10738125

3

Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation.

Perabo FG, Kamp S, Schmidt D, Lindner H, Steiner G, Mattes RH, Wirger A, Pegelow K, Albers P, Kohn EC, von Ruecker A, Mueller SC. Perabo FG, et al. Among authors: schmidt d. Br J Cancer. 2001 May 18;84(10):1330-8. doi: 10.1054/bjoc.2001.1808. Br J Cancer. 2001. PMID: 11355943 Free PMC article.

4

Soluble Fas and Fas-ligand in bladder cancer in vitro and in vivo.

Perabo FG, Mattes RH, Wirger A, Steiner G, Kamp S, Schmidt D, Pegelow K, von Ruecker A, Müller SC. Perabo FG, et al. Among authors: schmidt d. Urol Oncol. 2001 Jul;6(4):163-169. doi: 10.1016/s1078-1439(00)00130-7. Urol Oncol. 2001. PMID: 11418323

5

Preclinical evaluation of a radiosensitizing effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cells.

Fechner G, Perabo FG, Schmidt DH, Haase L, Ludwig E, Schueller H, Blatter J, Mller SC, Albers P. Fechner G, et al. Among authors: schmidt dh. Urology. 2003 Feb;61(2):468-73. doi: 10.1016/s0090-4295(02)02156-8. Urology. 2003. PMID: 12597983

6

Angiogenetic protooncogene ets-1 induced neovascularization is involved in the metastatic process of testicular germ cell tumors.

Adam M, Schmidt D, Wardelmann E, Wernert N, Albers P. Adam M, et al. Among authors: schmidt d. Eur Urol. 2003 Sep;44(3):329-36. doi: 10.1016/s0302-2838(03)00262-8. Eur Urol. 2003. PMID: 12932931

7

PIAS/SUMO: new partners in transcriptional regulation.

Schmidt D, Müller S. Schmidt D, et al. Cell Mol Life Sci. 2003 Dec;60(12):2561-74. doi: 10.1007/s00018-003-3129-1. Cell Mol Life Sci. 2003. PMID: 14685683 Free PMC article. Review.

8

Preclinical evaluation of gemcitabine/paclitaxel-interactions in human bladder cancer lines.

Perabo FG, Lindner H, Schmidt D, Huebner D, Blatter J, Fimmers R, Müller SC, Albers P. Perabo FG, et al. Among authors: schmidt d. Anticancer Res. 2003 Nov-Dec;23(6C):4805-14. Anticancer Res. 2003. PMID: 14981929

9

Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2.

Perabo FG, Wirger A, Kamp S, Lindner H, Schmidt DH, Müller SC, Kohn EC. Perabo FG, et al. Anticancer Res. 2004 Sep-Oct;24(5A):2869-77. Anticancer Res. 2004. PMID: 15517890 Free article.

10

GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?

Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A. Bastian PJ, et al. Among authors: schmidt d. Eur J Med Res. 2004 Nov 29;9(11):523-7. Eur J Med Res. 2004. PMID: 15649863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,161 results

Search Page

Filters